Key facts
- Prospyr’s last known valuation is $50.6M (Dec 2025).
- It has raised $18.6M; the latest was PE Growth/Expansion ($13.6M) in Dec 2025.
- Notable investors include Bienville Capital, Five Elms Capital, Bessemer Investors, Fractal Software.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Prospyr
- ·The full record, as it builds
Funding rounds
No funding rounds for Prospyr are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prospyr
Developer of an aesthetic practices platform designed to offer practice management tools. The company's platform provides a data archive, social media integration, targeted email marketing, task management, review management, and other related features, enabling aesthetic medicine practitioners to efficiently attract, serve, and retain the growing population of aesthetic patients.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2021
- Employees
- 9
- Website
- prospyrmed.com/
- Ownership
- Privately Held (backing)
Prospyr doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prospyr shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prospyr in its N-PORT filings yet. We sweep new filings monthly.